ValueinValuein

SIONSionna Therapeutics, Inc.

Health Care

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents revised up 2.5% for Q1 2024

This is the 5th largest revision in SION's history.

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

Q1 2024

Notable restatement

As reported

$37.8M

Restated

$38.8M
2.5%
Verify against SEC filingsShow
As reported$37.8M
Accepted 2025-05-120002036042-25-000016
Restated$38.8M
Accepted 2026-05-120001628280-26-033876

CashAndEquivalents · reported 3 times · point-in-time, survivorship-free. Every figure traces to its filing above.

Track this the moment it happens

Get an alert the next time SION — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.

Get restatement alertsSee SION financialsMore restatements
SION — Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents revised up 2.5% for Q1 2024 · Valuein Radar | Valuein